- £957.79m
- £2.16bn
- £1.36bn
- 48
- 48
- 87
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19 | ||
| PEG Ratio (f) | 0.67 | ||
| EPS Growth (f) | 39.4% | ||
| Dividend Yield (f) | 1.37% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.29 | ||
| Price to Tang. Book | 3.18 | ||
| Price to Free Cashflow | 7.31 | ||
| Price to Sales | 0.7 | ||
| EV to EBITDA | 9.56 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.4% | ||
| Return on Equity | 3.71% | ||
| Operating Margin | 9.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 980.8 | 557.2 | 1,048.1 | 1,195 | 1,359 | 1,535.41 | 1,624.91 | 7.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -68.3 | n/a | n/a | n/a | +82.79 | +38 | +40.6 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, ear, nose and throat, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, hematology, hand surgery, heart treatments, hip and knee, kidney treatments, men's health, neurosurgery and neurology, pediatrics, physiotherapy, podiatry, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.
Directors
- Ian Cheshire NEC
- Justinian Ash CEO (56)
- Martin Angle NVC (70)
- Jitesh Sodha CFO (53)
- John Forrest COO (49)
- Gillian Fairfield GCN
- Shelley Thomas DHR
- Cathy Cale OTH
- Peter Corfield OTH (49)
- Alison Dickinson OTH
- Ronnie Van Der Merwe NED (57)
- Adele Anderson NID (54)
- Anthony Bourne NID
- Janet Husband NID (78)
- Jenny Kay NID
- Simon Rowlands NID (63)
- Clifford Shearman NID
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 12th, 2014
- Public Since
- July 18th, 2014
- No. of Shareholders
- 512
- No. of Employees
- 16,800
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 404,132,234
- Address
- 3 Dorset Rise, LONDON, EC4Y 8EN
- Web
- https://www.spirehealthcare.com/
- Phone
- Contact
- Angus Prentice
- Auditors
- Ernst & Young LLP
Latest News for SPI
Upcoming Events for SPI
Half Year 2024 Spire Healthcare Group PLC Earnings Release
Similar to SPI
Burning Rock Biotech
London Stock Exchange
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Hellenic Dynamics
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
FAQ
As of Today at 23:26 UTC, shares in Spire Healthcare are trading at 237.00p. This share price information is delayed by 15 minutes.
Shares in Spire Healthcare last closed at 237.00p and the price had moved by +4.18% over the past 365 days. In terms of relative price strength the Spire Healthcare share price has underperformed the FTSE All Share Index by -2.17% over the past year.
The overall consensus recommendation for Spire Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Spire Healthcare dividend yield is 0.89% based on the trailing twelve month period.
Last year, Spire Healthcare paid a total dividend of £0.02, and it currently has a trailing dividend yield of 0.89%.Looking ahead, the next dividend pay date is 2024-06-21.
We do not have data on when Spire Healthcare is to next pay dividends. The historic dividend yield on Spire Healthcare shares is currently 0.89%.
To buy shares in Spire Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 237.00p, shares in Spire Healthcare had a market capitalisation of £957.79m.
Here are the trading details for Spire Healthcare:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SPI
Based on an overall assessment of its quality, value and momentum Spire Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Spire Healthcare is 305.71p. That is 28.99% above the last closing price of 237.00p.
Analysts covering Spire Healthcare currently have a consensus Earnings Per Share (EPS) forecast of £0.11 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Spire Healthcare. Over the past six months, its share price has underperformed the FTSE All Share Index by -2.12%.
As of the last closing price of 237.00p, shares in Spire Healthcare were trading +2.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Spire Healthcare PE ratio based on its reported earnings over the past 12 months is 19. The shares last closed at 237.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Spire Healthcare's management team is headed by:
- Ian Cheshire - NEC
- Justinian Ash - CEO
- Martin Angle - NVC
- Jitesh Sodha - CFO
- John Forrest - COO
- Gillian Fairfield - GCN
- Shelley Thomas - DHR
- Cathy Cale - OTH
- Peter Corfield - OTH
- Alison Dickinson - OTH
- Ronnie Van Der Merwe - NED
- Adele Anderson - NID
- Anthony Bourne - NID
- Janet Husband - NID
- Jenny Kay - NID
- Simon Rowlands - NID
- Clifford Shearman - NID